CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Total
Beginning balance at Dec. 31, 2023	$ 638,150	$ 575,184	$ (11,334)	$ 1,202,000
Beginning balance (in shares) at Dec. 31, 2023	57,858
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		28,240		28,240
Other comprehensive income (loss)			(1,122)	(1,122)
Stock-based compensation expense	$ 4,934			4,934
Options exercised	$ 7,394			7,394
Options exercised (in shares)	213
Issuance of common stock under Employee Stock Purchase Plan	$ 336			336
Issuance of common stock under Employee Stock Purchase Plan (in shares)	5
Shares issued from time-vested restricted stock units (in shares)	47
Shares surrendered in exchange for payment of payroll tax liabilities	$ (1,592)			(1,592)
Shares surrendered in exchange for payment of payroll tax liabilities (in shares)	(21)
Ending balance at Mar. 31, 2024	$ 649,222	603,424	(12,456)	1,240,190
Ending balance (in shares) at Mar. 31, 2024	58,102
Beginning balance at Dec. 31, 2023	$ 638,150	575,184	(11,334)	1,202,000
Beginning balance (in shares) at Dec. 31, 2023	57,858
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)				92,410
Other comprehensive income (loss)				(2,061)
Ending balance at Sep. 30, 2024	$ 669,207	667,594	(13,395)	1,323,406
Ending balance (in shares) at Sep. 30, 2024	58,274
Beginning balance at Mar. 31, 2024	$ 649,222	603,424	(12,456)	1,240,190
Beginning balance (in shares) at Mar. 31, 2024	58,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		35,726		35,726
Other comprehensive income (loss)			(2,973)	(2,973)
Stock-based compensation expense	$ 6,301			6,301
Options exercised	$ 2,913			2,913
Options exercised (in shares)	66
Issuance of common stock under Employee Stock Purchase Plan	$ 288			288
Issuance of common stock under Employee Stock Purchase Plan (in shares)	4
Shares issued from time-vested restricted stock units (in shares)	20
Ending balance at Jun. 30, 2024	$ 658,724	639,150	(15,429)	1,282,445
Ending balance (in shares) at Jun. 30, 2024	58,192
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		28,444		28,444
Other comprehensive income (loss)			2,034	2,034
Stock-based compensation expense	$ 5,990			5,990
Options exercised	$ 4,247			4,247
Options exercised (in shares)	80
Issuance of common stock under Employee Stock Purchase Plan	$ 246			246
Issuance of common stock under Employee Stock Purchase Plan (in shares)	2
Ending balance at Sep. 30, 2024	$ 669,207	667,594	(13,395)	1,323,406
Ending balance (in shares) at Sep. 30, 2024	58,274
Beginning balance at Dec. 31, 2024	$ 703,219	695,541	(19,401)	$ 1,379,359
Beginning balance (in shares) at Dec. 31, 2024	58,743			58,743
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		30,147		$ 30,147
Other comprehensive income (loss)			4,025	4,025
Stock-based compensation expense	$ 7,885			7,885
Options exercised	$ 14,610			14,610
Options exercised (in shares)	281
Issuance of common stock under Employee Stock Purchase Plan	$ 424			424
Issuance of common stock under Employee Stock Purchase Plan (in shares)	4
Shares issued from time-vested restricted stock units (in shares)	130
Shares surrendered in exchange for payment of payroll tax liabilities	$ (6,145)			(6,145)
Shares surrendered in exchange for payment of payroll tax liabilities (in shares)	(62)
Shares surrendered in exchange for exercise of stock options	$ (1,882)			(1,882)
Shares surrendered in exchange for exercise of stock options (in shares)	(18)
Ending balance at Mar. 31, 2025	$ 718,111	725,688	(15,376)	1,428,423
Ending balance (in shares) at Mar. 31, 2025	59,078
Beginning balance at Dec. 31, 2024	$ 703,219	695,541	(19,401)	$ 1,379,359
Beginning balance (in shares) at Dec. 31, 2024	58,743			58,743
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)				$ 90,483
Other comprehensive income (loss)				15,682
Shares surrendered in exchange for exercise of stock options				(10,863)
Ending balance at Sep. 30, 2025	$ 747,103	786,024	(3,719)	$ 1,529,408
Ending balance (in shares) at Sep. 30, 2025	59,290			59,290
Beginning balance at Mar. 31, 2025	$ 718,111	725,688	(15,376)	$ 1,428,423
Beginning balance (in shares) at Mar. 31, 2025	59,078
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		32,581		32,581
Other comprehensive income (loss)			10,314	10,314
Stock-based compensation expense	$ 9,868			9,868
Options exercised	$ 6,523			6,523
Options exercised (in shares)	114
Issuance of common stock under Employee Stock Purchase Plan	$ 339			339
Issuance of common stock under Employee Stock Purchase Plan (in shares)	4
Shares issued from time-vested restricted stock units (in shares)	22
Ending balance at Jun. 30, 2025	$ 734,841	758,269	(5,062)	1,488,048
Ending balance (in shares) at Jun. 30, 2025	59,218
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)		27,755		27,755
Other comprehensive income (loss)			1,343	1,343
Stock-based compensation expense	$ 12,549			12,549
Options exercised	$ 10,853			10,853
Options exercised (in shares)	195
Issuance of common stock under Employee Stock Purchase Plan	$ 293			293
Issuance of common stock under Employee Stock Purchase Plan (in shares)	4
Shares surrendered in exchange for payment of payroll tax liabilities	$ (2,452)			(2,452)
Shares surrendered in exchange for payment of payroll tax liabilities (in shares)	(27)
Shares surrendered in exchange for exercise of stock options	$ (8,981)			(8,981)
Shares surrendered in exchange for exercise of stock options (in shares)	(100)
Ending balance at Sep. 30, 2025	$ 747,103	$ 786,024	$ (3,719)	$ 1,529,408
Ending balance (in shares) at Sep. 30, 2025	59,290			59,290